Q4 2020 Holdings
Filed 2021-02-12 | 21 holdings | $687.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals(CPIX) | COM | 230770109 | $557.0K | 188,703 | 81.1% |
| Ligand Pharmaceuticals(LGND) | COM NEW | 53220K504 | $32.4K | 326,100 | 4.7% |
| Amryt Pharma LTD - Spnr ADR | SPONSORED ADS | 03217L106 | $20.1K | 1,416,483 | 2.9% |
| Diamedica Therapeutics Inc(DMAC) | COM NEW | 25253X207 | $9.6K | 950,000 | 1.4% |
| Aytu Bioscience Inc(AYTUUSD) | COM | 054754874 | $8.4K | 1,398,776 | 1.2% |
| Apollo Endosurgery Inc(HQ8F) | COM | 03767D108 | $7.9K | 2,326,165 | 1.2% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $6.6K | 2,054,000 | 1.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.5K | 800,000 | 0.8% |
| Xoma Corp(XOMA) | COM NEW | 98419J206 | $5.5K | 124,130 | 0.8% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $5.3K | 834,449 | 0.8% |
| Scynexis Inc(SCYX) | COM NEW | 811292200 | $5.2K | 685,000 | 0.8% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $3.5K | 808,431 | 0.5% |
| Strongbridge Biopharma PLC | SHS USD | G85347105 | $3.3K | 1,350,000 | 0.5% |
| Gamida Cell LTD | SHS | M47364100 | $3.2K | 379,470 | 0.5% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $3.1K | 721,307 | 0.5% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $3.1K | 4,962,657 | 0.5% |
| Novus Therapeutics Inc | COM | 67011N204 | $2.6K | 167,333 | 0.4% |
| Yumanity Therapeutics Inc | COM | 98872L102 | $1.9K | 108,847 | 0.3% |
| Affimed NV | COM | N01045108 | $1.3K | 219,340 | 0.2% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $970 | 500,000 | 0.1% |
| Aptevo Therapeutics Inc(APVOEUR) | COM NEW | 03835L207 | $670 | 18,280 | 0.1% |